Stephen E. Sallan

33.5k total citations · 6 hit papers
282 papers, 21.5k citations indexed

About

Stephen E. Sallan is a scholar working on Public Health, Environmental and Occupational Health, Pediatrics, Perinatology and Child Health and Molecular Biology. According to data from OpenAlex, Stephen E. Sallan has authored 282 papers receiving a total of 21.5k indexed citations (citations by other indexed papers that have themselves been cited), including 166 papers in Public Health, Environmental and Occupational Health, 113 papers in Pediatrics, Perinatology and Child Health and 64 papers in Molecular Biology. Recurrent topics in Stephen E. Sallan's work include Acute Lymphoblastic Leukemia research (165 papers), Childhood Cancer Survivors' Quality of Life (105 papers) and Chemotherapy-induced cardiotoxicity and mitigation (36 papers). Stephen E. Sallan is often cited by papers focused on Acute Lymphoblastic Leukemia research (165 papers), Childhood Cancer Survivors' Quality of Life (105 papers) and Chemotherapy-induced cardiotoxicity and mitigation (36 papers). Stephen E. Sallan collaborates with scholars based in United States, Canada and Puerto Rico. Stephen E. Sallan's co-authors include Lewis B. Silverman, Richard D. Gelber, Steven E. Lipshultz, Steven D. Colan, Donna Neuberg, Stuart R. Lipsitz, Scott A. Armstrong, Luis A. Clavell, Stephen P. Sanders and Antonio R. Pérez‐Atayde and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Stephen E. Sallan

277 papers receiving 20.9k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia

2001 1.3k citations Scott A. Armstrong, Lewis B. Silverman et al. profile →
Late Cardiac Effects of Doxorubicin Therapy for Acute Lymphoblastic Leukemia in Childhood

1991 1.0k citations Steven E. Lipshultz, Steven D. Colan et al. profile →
Female Sex and Higher Drug Dose as Risk Factors for Late Cardiotoxic Effects of Doxorubicin Therapy for Childhood Cancer

1995 584 citations Steven E. Lipshultz, Stuart R. Lipsitz et al. profile →
An oncogenic super-enhancer formed through somatic mutation of a noncoding intergenic element

2014 538 citations Marc R. Mansour, Brian J. Abraham et al. Science profile →
Chronic Progressive Cardiac Dysfunction Years After Doxorubicin Therapy for Childhood Acute Lymphoblastic Leukemia

2005 512 citations Steven E. Lipshultz, Stuart R. Lipsitz et al. Journal of Clinical Oncology profile →
Long-term Cardiovascular Toxicity in Children, Adolescents, and Young Adults Who Receive Cancer Therapy: Pathophysiology, Course, Monitoring, Management, Prevention, and Research Directions

2013 388 citations Steven E. Lipshultz, Steven D. Colan et al. Circulation profile →

Peers

Countries citing papers authored by Stephen E. Sallan

Since Specialization

Citations

This map shows the geographic impact of Stephen E. Sallan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen E. Sallan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen E. Sallan more than expected).

Fields of papers citing papers by Stephen E. Sallan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen E. Sallan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen E. Sallan. The network helps show where Stephen E. Sallan may publish in the future.

Co-authorship network of co-authors of Stephen E. Sallan

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen E. Sallan. A scholar is included among the top collaborators of Stephen E. Sallan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen E. Sallan. Stephen E. Sallan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Treatment completion, asparaginase completion, and oncologic outcomes among children, adolescents and young adults with acute lymphoblastic leukemia treated with DFCI Consortium Protocols 2024 ·Leukemia ·Yannis K. Valtis, Yael Flamand, Shai Shimony, Andrew E. Place, Lewis B. Silverman, Lynda M. Vrooman, Andrew M. Brunner, Stephen E. Sallan, Martha Wadleigh, Richard M. Stone, Daniel J. DeAngelo, Marlise R. Luskin	5
2	Protective Effects of Dietary Intake of Antioxidants and Treatment-Related Toxicity in Childhood Leukemia: A Report From the DALLT Cohort 2020 ·Journal of Clinical Oncology ·Elena J. Ladas, Traci M. Blonquist, Mäneka Puligandla, Manuela Orjuela, Kristen E. Stevenson, Peter D. Cole, Uma H. Athale, Luis A. Clavell, Jean-Marie Leclerc, Caroline Laverdière, Bruno Michon, Marshall A. Schorin, Jennifer Welch, Barbara L. Asselin, Stephen E. Sallan, Lewis B. Silverman, Kara M. Kelly	10
3	An Anatomical Site and Genetic-Based Prognostic Model for Patients With Nuclear Protein in Testis (NUT) Midline Carcinoma: Analysis of 124 Patients 2019 ·JNCI Cancer Spectrum ·Nicole G. Chau, Clement Ma, (unknown), Hasan Al‐Sayegh, Valentina Nardi, (unknown), Christopher S. Lathan, Steven G. DuBois, Robert I. Haddad, Geoffrey I. Shapiro, Stephen E. Sallan, Arindam Dhar, Jeanenne J. Nelson, Christopher A. French	131
4	Phase I trial of the mTOR inhibitor everolimus in combination with multi‐agent chemotherapy in relapsed childhood acute lymphoblastic leukemia 2018 ·Pediatric Blood & Cancer ·Andrew E. Place, Yana Pikman, Kristen E. Stevenson, Marian H. Harris, Melinda Pauly, Maria Luisa Sulis, Nobuko Hijiya, Lia Gore, Todd M. Cooper, Mignon L. Loh, Giovanni Roti, Donna Neuberg, Sarah K. Hunt, (unknown), Kimberly Stegmaier, Stephen E. Sallan, Lewis B. Silverman	43
5	How Variable Is Our Delivery of Information? Approaches to Patient Education About Oral Chemotherapy in the Pediatric Oncology Clinic 2016 ·Journal of Pediatric Health Care ·Justine M. Kahn, Uma H. Athale, Luis A. Clavell, Peter D. Cole, Jean-Marie Leclerc, Caroline Laverdière, Bruno Michon, Marshall A. Schorin, Jennifer Welch, Stephen E. Sallan, Lewis B. Silverman, Kara M. Kelly	8
6	Cardiovascular Disease in Adult Survivors of Childhood Cancer 2015 ·Annual Review of Medicine ·Steven E. Lipshultz, Vivian I. Franco, Tracie L. Miller, Steven D. Colan, Stephen E. Sallan	88
7	An oncogenic super-enhancer formed through somatic mutation of a noncoding intergenic element breakdown → 2014 ·Science ·Marc R. Mansour, Brian J. Abraham, Lars Anders, Alla Berezovskaya, Alejandro Gutiérrez, Adam D. Durbin, Julia Etchin, Lee N. Lawton, Stephen E. Sallan, Lewis B. Silverman, Mignon L. Loh, Stephen P. Hunger, Takaomi Sanda, Richard A. Young, A. Thomas Look	538
8	Polymorphisms of Asparaginase Pathway and Asparaginase-Related Complications in Children with Acute Lymphoblastic Leukemia 2014 ·Clinical Cancer Research ·(unknown), (unknown), Francesco Ceppi, (unknown), Vincent Gagné, Julie Rousseau, Malgorzata Labuda, Lewis B. Silverman, Stephen E. Sallan, Donna Neuberg, Jeffery L. Kutok, Daniel Sinnett, Caroline Laverdière, Maja Krajinović	50
9	Maturation Stage of T-cell Acute Lymphoblastic Leukemia Determines BCL-2 versus BCL-XL Dependence and Sensitivity to ABT-199 2014 ·Cancer Discovery ·Tríona Ní Chonghaile, Justine E. Roderick, (unknown), Jeremy Ryan, Stephen E. Sallan, Lewis B. Silverman, Mignon L. Loh, Stephen P. Hunger, Brent L. Wood, Daniel J. DeAngelo, Richard M. Stone, Marian H. Harris, Alejandro Gutiérrez, Michelle A. Kelliher, Anthony Letai	190
10	Postinduction Dexamethasone and Individualized Dosing of Escherichia Coli L-Asparaginase Each Improve Outcome of Children and Adolescents With Newly Diagnosed Acute Lymphoblastic Leukemia: Results From a Randomized Study—Dana-Farber Cancer Institute ALL Consortium Protocol 00-01 2013 ·Journal of Clinical Oncology ·Lynda M. Vrooman, Kristen E. Stevenson, Jeffrey G. Supko, Jane O’Brien, Suzanne E. Dahlberg, Barbara L. Asselin, Uma H. Athale, Luis A. Clavell, Kara M. Kelly, Jeffery L. Kutok, Caroline Laverdière, Steven E. Lipshultz, Bruno Michon, Marshall A. Schorin, Mary V. Relling, Harvey J. Cohen, Donna Neuberg, Stephen E. Sallan, Lewis B. Silverman	227
11	Bim Polymorphisms: Influence on Function and Response to Treatment in Children with Acute Lymphoblastic Leukemia 2013 ·Clinical Cancer Research ·Vincent Gagné, Julie Rousseau, Malgorzata Labuda, (unknown), Ivan Brukner, Caroline Laverdière, Francesco Ceppi, Stephen E. Sallan, Lewis B. Silverman, Donna Neuberg, Jeffery L. Kutok, Daniel Sinnett, Maja Krajinović	17
12	Clinicopathologic Features and Long-term Outcomes of NUT Midline Carcinoma 2012 ·Clinical Cancer Research ·Daniel E. Bauer, Chelsey M. Mitchell, Kelly M. Strait, Christopher S. Lathan, Edward B. Stelow, Sonja Lüer, Somala Muhammed, Andrew G. Evans, Lynette M. Sholl, Juan Rosaí, Eugenia Giraldi, Richard Oakley, Carlos Rodríguez‐Galindo, Wendy B. London, Stephen E. Sallan, James E. Bradner, Christopher A. French	276
13	Changes in Cardiac Biomarkers During Doxorubicin Treatment of Pediatric Patients With High-Risk Acute Lymphoblastic Leukemia: Associations With Long-Term Echocardiographic Outcomes 2012 ·Journal of Clinical Oncology ·Steven E. Lipshultz, Tracie L. Miller, Rebecca E. Scully, Stuart R. Lipsitz, Nader Rifai, Lewis B. Silverman, Steven D. Colan, Donna Neuberg, Suzanne E. Dahlberg, Jacqueline Henkel, Barbara L. Asselin, Uma H. Athale, Luis A. Clavell, Caroline Laverdière, Bruno Michon, Marshall A. Schorin, Stephen E. Sallan	227
14	Differentiation of NUT Midline Carcinoma by Epigenomic Reprogramming 2011 ·Cancer Research ·Brian E. Schwartz, Matthias D. Hofer, Madeleine E. Lemieux, (unknown), Michael J. Cameron, Nathan West, Elin S. Agoston, Nicolas Reynoird, Saadi Khochbin, Tan A. Ince, Amanda L. Christie, Katherine A. Janeway, Sara O. Vargas, Antonio R. Pérez‐Atayde, Jon C. Aster, Stephen E. Sallan, Andrew L. Kung, James E. Bradner, Christopher A. French	156
15	Targeting of active mTOR inhibits primary leukemia T cells and synergizes with cytotoxic drugs and signaling inhibitors 2011 ·Experimental Hematology ·Ana Batista, João T. Barata, Elke Raderschall, Stephen E. Sallan, Nadia Carlesso, Lee M. Nadler, Angelo A. Cardoso	42
16	Absence of Biallelic TCR γ Deletion Predicts Early Treatment Failure in Pediatric T-Cell Acute Lymphoblastic Leukemia 2010 ·Journal of Clinical Oncology ·Alejandro Gutiérrez, Suzanne E. Dahlberg, Donna Neuberg, Jianhua Zhang, Ruta Grebliunaite, Takaomi Sanda, Alexei Protopopov, Valeria Tosello, Jeffery L. Kutok, Richard A. Larson, Michael J. Borowitz, Mignon L. Loh, Adolfo A. Ferrando, Stuart S. Winter, Charles G. Mullighan, Lewis B. Silverman, Lynda Chin, Stephen P. Hunger, Stephen E. Sallan, A. Thomas Look	69
17	Abstract 20432: Diagnostic Value of Cardiac Troponin T, N-Terminal Pro-Brain Natriuretic Peptide, and High-Sensitivity C-Reactive Protein During Doxorubicin Therapy in Children with Acute Lymphoblastic Leukemia 2010 ·Circulation ·Steven E. Lipshultz, Tracie L. Miller, Rebecca E. Scully, Stuart R. Lipsitz, Nader Rifai, Lewis B. Silverman, Steven D. Colan, Donna Neuberg, Suzanne E. Dahlberg, Jacqueline Henkel, Barbara L. Asselin, Uma H. Athale, Luis A. Clavell, Caroline Laverdière, Bruno Michon, Marshall A. Schorin, Stephen E. Sallan	2
18	Gene Expression Profiling Identifies BAX-δ as a Novel Tumor Antigen in Acute Lymphoblastic Leukemia 2005 ·Cancer Research ·(unknown), W. Nicholas Haining, Sascha Ansén, Zhinan Xia, Scott A. Armstrong, Nilufer P. Seth, Paolo Ghia, Monique L. den Boer, Rob Pieters, Stephen E. Sallan, Lee M. Nadler, Angelo A. Cardoso	28
19	Cognitive Sequelae in Children Treated for Acute Lymphoblastic Leukemia With Dexamethasone or Prednisone 2000 ·The American journal of pediatric hematology/oncology ·Deborah P. Waber, Sarah C. Carpentieri, Neil Klar, Lewis B. Silverman, Molly Schwenn, Craig A. Hurwitz, Phyllis J. Mullenix, Nancy J. Tarbell, Stephen E. Sallan	118
20	Intensified therapy for infants with acute lymphoblastic leukemia: results from the Dana-Farber Cancer Institute Consortium. 1997 ·PubMed ·Lewis B. Silverman, Thomas W. McLean, Richard D. Gelber, (unknown), D. Gary Gilliland, N.J. Tarbell, Stephen E. Sallan	81

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact